Trial Profile
The effectiveness of preventing premature luteinizing hormone surge by cetrorelix in the controlled ovarian stimulation by letrozole and gonadotropin
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 09 Jan 2021
Price :
$35
*
At a glance
- Drugs Cetrorelix (Primary) ; Follitropin alfa; Letrozole
- Indications Infertility
- Focus Pharmacodynamics
- 17 Nov 2008 Status changed from not stated to completed, according to results published in Fertility and Sterility.
- 02 Nov 2006 New trial record.